HTS News 19.62 Hatteras Financial Corp (HTS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hatteras Financial Corp (HTS) 19.62 $HTS

Pre-market REITs Picks -- Research on Hatteras Financial, Resource Capital, American Capital Mortgage Investment, and Capstead Mortgage
PR Newswire - Tue Apr 15, 10:09AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the S&P 500 finished the session 0.82% higher at 1,830.61 and the NASDAQ Composite closed at 4,022.69, up 0.57%. The Dow Jones Industrial Average finished at 16,173.24, up 0.91%. During the session, all the ten sectors ended in positive. The S&P 500 Financials Sector Index closed the day at 289.10, up 0.79%, but the same has declined 1.43% in the last one month. Investor-Edge has initiated coverage on the following equities: Hatteras Financial Corp. (NYSE: HTS), Resource Capital Corp. (NYSE: RSO), American Capital Mortgage Investment Corp. (NASDAQ: MTGE) and Capstead Mortgage Corp. (NYSE: CMO). Free technical research on HTS, RSO, MTGE and CMO can be downloaded upon signing up at:

Hatteras Financial Corp. Announces Conference Call to Discuss First Quarter 2014 Results
Business Wire - Tue Apr 15, 6:00AM CDT
Hatteras Financial Corp. (NYSE:HTS) ("Hatteras" or the "Company" today announced it will conduct a conference call at 10:00 a.m. ET on Wednesday, April 23, 2014, to discuss the Company's financial results for the quarter ended March 31, 2014. Hosting the call will be Michael R. Hough, Chairman and Chief Executive Officer, Benjamin M. Hough, President and Chief Operating Officer, and Kenneth A. Steele, Chief Financial Officer, along with other members of the Company's senior management team.

Financial Companies Report Appointments, Agreements, Dividends and Stock Movements - Analyst Notes on JPMorgan Chase, SEI Investments, JLL, Hatteras Financial, and Hudson Pacific Properties
PR Newswire - Wed Apr 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding JPMorgan Chase & Co. (NYSE: JPM), SEI Investments Co. (NASDAQ: SEIC), Jones Lang LaSalle Inc. (NYSE: JLL), Hatteras Financial Corp (NYSE: HTS), and Hudson Pacific Properties, Inc. (NYSE: HPP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: ELS, HTS, FLS
at The Street - Tue Mar 25, 9:00AM CDT
ELS HTS FLS are going ex-dividend tomorrow, Wednesday, March 26, 2014, 4:00 AM ET

Downgrade Alert for Hatteras Financial (HTS)
Comtex SmarTrend(R) - Tue Mar 25, 7:01AM CDT
Hatteras Financial (NYSE:HTS) was downgraded from Buy to Neutral at Compass Point today. The stock closed yesterday at $19.29 on volume of 1.2 million shares, above average daily volume of 1.0 million. There is potential upside of 1.7% for shares of Hatteras Financial based on a current price of $19.29 and an average consensus analyst price target of $19.61. The stock should discover initial support at its 200-day moving average (MA) of $19.27 and subsequent support at its 50-day MA of $18.80.

Hatteras Financial announces Q1 2014 dividends on common and preferred Stock
M2 - Wed Mar 19, 8:02AM CDT
The board of directors of a real estate investment trust, Hatteras Financial Corp (NYSE:HTS) authorised common and preferred stock cash dividends for the first quarter of 2014, the company revealed on Tuesday.

Hatteras Financial Corp. Declares First Quarter 2014 Dividends on Shares of Common and Preferred Stock
Business Wire - Tue Mar 18, 3:01PM CDT
The Board of Directors of Hatteras Financial Corp. (NYSE: HTS) (the "Company" today declared cash dividends on shares of both its common and preferred stock for the first quarter of 2014.

REIT Industry Review & Stock Picks - Feb 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 2:39AM CST
REIT Industry Review & Stock Picks - Feb 2014 - Industry Outlook

REIT Industry Review & Stock Picks - Feb 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 2:39AM CST
REIT Industry Review & Stock Picks - Feb 2014 - Zacks Analyst Interviews

What You Need to Know About These Dividend Monsters
Patrick Morris, The Motley Fool - Motley Fool - Fri Feb 14, 5:50AM CST
Photo credit:  www.LendingMemo.com . The latest quarterly results from two stocks with dividends higher than 10% are in, and while the mortgage real estate investment trust, or mREIT, industry had a tough year, Hatteras Financial and CYS...

1 Dividend Stock’s Big New Purchase
David Hanson and Matt Koppenheffer, The Motley Fool - Motley Fool - Wed Feb 12, 8:34AM CST
CYS Investments reported quarterly earnings this week, but mREIT investors are still discussing American Capital Agency 's new decision to invest in the equity of other mREITs. In this segment of The Motley Fool's financials-focused show, ...

Hatteras Financial Corp. Announces Fourth Quarter 2013 Financial Results
Business Wire - Tue Feb 11, 3:42PM CST
Hatteras Financial Corp. (NYSE: HTS) ("Hatteras" or the "Company" today announced financial results for the quarter ended December 31, 2013.

1 mREIT's Secret Purchase... Revealed!
Amanda Alix, The Motley Fool - Motley Fool - Tue Feb 11, 11:59AM CST
Source:  KDS444 When American Capital Agency and American Capital Mortgage reported earnings recently, the fact that both mortgage REITs revealed earnings-per-share losses was lost in the shuffle surrounding some astounding news. On the...

Hatteras Financial Corp. Announces Conference Call to Discuss Fourth Quarter 2013 Results
Business Wire - Mon Feb 03, 10:31AM CST
Hatteras Financial Corp. (NYSE:HTS) ("Hatteras" or the "Company" today announced it will conduct a conference call at 10:00 a.m. ET on Wednesday February 12, 2014, to discuss the Company's financial results for the quarter ended December 31, 2013. Hosting the call will be Michael R. Hough, Chairman and Chief Executive Officer, Benjamin M. Hough, President and Chief Operating Officer, and Kenneth A. Steele, Chief Financial Officer, along with other members of the Company's senior management team.

Shares of HTS Down 32.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 21, 5:11PM CST
SmarTrend identified a Downtrend for Hatteras Financial (NYSE:HTS) on May 13th, 2013 at $26.42. In approximately 8 months, Hatteras Financial has returned 32.46% as of today's recent price of $17.84.

Hatteras Financial Shares Down 33.1% Since SmarTrend's Sell Call (HTS)
Comtex SmarTrend(R) - Tue Jan 14, 11:10AM CST
SmarTrend identified a Downtrend for Hatteras Financial (NYSE:HTS) on May 13th, 2013 at $26.42. In approximately 8 months, Hatteras Financial has returned 33.11% as of today's recent price of $17.67.

Hatteras Financial Has Returned 37.9% Since SmarTrend Recommendation (HTS)
Comtex SmarTrend(R) - Tue Dec 31, 9:16AM CST
SmarTrend identified a Downtrend for Hatteras Financial (NYSE:HTS) on May 13th, 2013 at $26.42. In approximately 8 months, Hatteras Financial has returned 37.88% as of today's recent price of $16.41.

Ex-Dividend Alert: 4 Stocks Going Ex-Dividend Tomorrow: ATAX, AT, HTS, SLG
at The Street - Thu Dec 26, 9:01AM CST
ATAX AT HTS SLG are going ex-dividend tomorrow, Friday, Dec. 27, 2013, 5:00 AM ET
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading